4.8 Article

Unraveling the C2-Symmetric Azatetraquinane System. Simple, Enantioselective Syntheses

期刊

ORGANIC LETTERS
卷 23, 期 6, 页码 2258-2262

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.orglett.1c00387

关键词

-

资金

  1. Pfizer Inc.
  2. Bristol-Myers Squibb

向作者/读者索取更多资源

A concise stereocontrolled synthetic route to the C-2-symmetric azatetraquinane 1 (or its enantiomer) has been described, involving innovation in methodology for [3+2] cycloaddition and stereochemical control.
Concise stereocontrolled synthetic routes to the C-2-symmetric azatetraquinane 1 (or, also, the enantiomer) are described. The successful execution of the synthesis involved innovation in the methodology for [3+2] cycloaddition and stereochemical control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据